Brand to Biosimilar Database
Brand | Available Biosimilar(s) | Therapeutic Category |
---|---|---|
Actemra® (tocilizumab) |
Tofidence™ (tocilizumab-bavi) |
rheumatoid arthritis, polyarticular juvenile idiopathic arthritis, systemic juvenile idiopathic arthritis |
Avastin® (bevacizumab) |
Alymsys® (bevacizumab-maly) |
colorectal cancer, lung cancer, glioblastoma cancer, kidney cancer, cervical cancer, ovarian cancer |
Enbrel® (etanercept) |
Erelzi® (Etanercept-szzs) |
rheumatoid arthritis, psoriatic arthritis, plaque psoriasis, ankylosing spondylitis, polyarticular juvenile idiopathic arthritis |
Epogen® (epoetin-alfa) |
Retacrit® (epoetin alfa-epbx) |
anemia |
Eylea® (aflibercept) |
Ahzantive® (aflibercept-mrbb) |
neovascular macular degeneration, macular edema, diabetic macular edema, diabetic retinopathy |
Herceptin® (trastuzumab) |
Hercessi™ (trastuzumab-strf) |
breast cancer, stomach cancer, esophageal cancer |
Humira® (adalimumab) |
Abrilada® (adalimumab-afzb) |
arthritis, plaque psoriasis, ankylosing spondylitis, Crohn’s disease, ulcerative colitis |
Lantus® (insulin glargine) |
Rezvoglar® (insulin glargine-aglr) |
diabetes |
Lucentis® (ranibizumab) |
Byooviz® (ranibizumab-nuna) |
macular degeneration, macular edema |
Neulasta® (pegfilgrastim) |
Fulphila® (pegfilgrastim-jmdb) |
neutropenia |
Neupogen® (filgrastim) |
Nivestym® (filgrastim-aafi) Releuko® (filgrastim-ayow) Zarxio® (filgrastim-sndz) |
neutropenia |
Prolia® (denosumab) |
Jubbonti® (denosumab-bbdz) |
osteoporosis, glucocorticoid-induced osteoporosis, nonmetastatic prostate cancer, breast cancer |
Remicade® (infliximab) |
Avsola® (infliximab-axxq) |
rheumatoid arthritis, psoriatic arthritis, ankylosing spondylitis, Crohn’s disease, plaque psoriasis, ulcerative colitis |
Rituxan® (rituximab) |
Riabni® (rituximab-arrx) |
non-Hodgkin’s lymphoma, lymphocytic leukemia, rheumatoid arthritis, granulomatosis with polyangiitis, microscopic polyangiitis, pemphigus vulgaris |
Soliris® (eculizumab) |
Bkemv™ (eculizumab-aeeb) |
paroxysmal nocturnal hemoglobinuria (PNH), atypical hemolytic uremic syndrome (aHUS) |
Stelara® (ustekinumab) |
Imuldosa (ustekinumab-srlf) |
plaque psoriasis, psoriatic arthritis |
Tysabri® (natalizumab) |
Tyruko™ (natalizumab-sztn) |
Crohn’s disease, multiple sclerosis |
Xgeva® (denosumab) |
Wyost® (denosumab-bbdz) |
multiple myeloma, hypercalcemia, bone metastases |